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The generation of diacylglycerol (DAG) is critical for promoting immune cell activation,
regulation, and function. Diacylglycerol kinase ζ (DGKζ ) serves as an important negative
regulator of DAG by enzymatically converting DAG into phosphatidic acid (PA) to shut
down DAG-mediated signaling. Consequently, the loss of DGKζ increases DAG levels
and the duration of DAG-mediated signaling. However, while the enhancement of DAG
signaling is thought to augment immune cell function, the loss of DGKζ can result
in both immunoactivation and immunomodulation depending on the cell type and
function. In this review, we discuss how different immune cell functions can be selectively
modulated by DGKζ . Furthermore, we consider how targeting DGKζ can be potentially
beneficial for the resolution of human diseases by either promoting immune responses
important for protection against infection or cancer or dampening immune responses in
immunopathologic conditions such as allergy and septic shock.
Keywords: diacylglycerol, diacylglycerol kinase, signal transduction, immunomodulation, phospholipase C,
extracellular signal-regulated kinase, phosphatidic acid
INTRODUCTION
Diacylglycerol (DAG) is a key secondary lipid messenger for transducing signals downstream of
many receptors expressed by hematopoietic cells. DAG has shown to be important in driving the
activation, proliferation, migration, and effector function of adaptive and innate immune cells.
The generation of DAG can be accomplished by the activation of various cell-surface receptors,
including Gq-mediated G-protein coupled receptors (GPCR)s (e.g., muscarinic and histamine
receptors) and immunoreceptor tyrosine-based activation motif (ITAM)-bearing receptors [e.g., T
cell receptor (TCR), FcεRI] (Topham and Prescott, 1999; Kambayashi and Koretzky, 2007; Smith-
Garvin et al., 2009; Wright et al., 2013). The activation of these receptors results in the formation
of proximal signaling complexes that are critical for the activation of phospholipase C (PLC). PLC
activation leads to enzymatic cleavage of phosphoinositol 4,5-bisphosphate (PIP2) into DAG and
inositol 1,4,5-triphosphate (IP3) (Imboden and Stobo, 1985). While IP3 mobilizes Ca
2+, DAG
activates the NF-κB and extracellular regulated kinase (ERK) pathways through protein kinase C
(PKC) and RasGRP, respectively, to promote cell function (Tognon et al., 1998; Coudronniere et al.,
2000; Dower et al., 2000; Sun et al., 2000; Wang et al., 2004; Quann et al., 2011). Consequently, the
levels of DAG must be tightly regulated to control the magnitude and duration of the responses
generated.
Diacylglycerol kinases (DGK) regulate DAG signaling by phosphorylating DAG and converting
it into phosphatidic acid (PA) (Topham and Prescott, 1999; Joshi and Koretzky, 2013). The loss
of DGKs increases DAG levels and the duration of DAG-mediated signaling. One might expect
that elevated DAG levels would lead to general enhancement of effector responses. However, the
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enhancement of DAG signaling through the loss of DGKs can
lead to either hyperactivation or hyporesponsiveness depending
on the cell type and the type of response. There are 10 different
isoforms comprising five different classes of DGKs, each of
which control different cellular functions based on their distinct
structural motifs and subcellular localization (Bunting et al.,
1996; Goto and Kondo, 1996; Topham and Prescott, 1999;
Kobayashi et al., 2007; Joshi and Koretzky, 2013). The threemajor
isoforms that are abundantly expressed in lymphoid tissues are
DGKα, DGKδ, and DGKζ (Shulga et al., 2011). In particular,
mice that lack the zeta (ζ ) isoform of DGK, which is highly
expressed in hematopoietic cells, display profound effects on
the functional behavior of various cell types. In the present
review, we will focus on how DGKζ plays both negative and
positive roles in immune responses mounted by different cell
types.
NEGATIVE REGULATION OF EFFECTOR
RESPONSES BY DGKζ
CD4+ and CD8+ Conventional T Cells
DGKζ serves as a critical negative regulator of DAG signaling
downstream of the TCR and can modulate the strength of
TCR signaling. Early experiments using the immortalized Jurkat
T cell line showed that overexpression of DGKζ inhibits
TCR signaling by reducing the levels of active GTP-bound
Ras and, consequently, diminishing ERK activation (Zhong
et al., 2002). Furthermore, the overexpression of DGKζ was
associated with decreased AP-1 transcription factor activity and
CD69 expression (an early T cell activation marker) following
TCR stimulation, both of which are regulated by the Ras-
ERK pathway. Importantly, Ca2+ flux was normal regardless
of DGKζ overexpression, suggesting that DGKζ selectively
regulated DAG-mediated signaling pathways downstream of the
TCR. Further biochemical analysis through the use of a kinase
dead DGKζ mutant revealed that the enzymatic activity of DGKζ
was critical for its inhibitory effects on TCR signaling.
To test the physiological role of DGKζ in T cells, Zhong
et al. generated DGKζ knockout mice (Zhong et al., 2003). Initial
phenotypic analysis showed that DGKζ KO mice contained
similar frequencies and numbers of CD4+ and CD8+ T cells
in secondary lymphoid organs and displayed no obvious defects
in lymphoid architecture or cellularity. Furthermore, thymic
development as analyzed by the number and frequency of
CD4 single-positive (SP), CD8 SP, double-positive (DP), and
double-negative (DN) thymocytes in DGKζ -deficient mice was
similar to wild-type (WT)mice. However, upon TCR stimulation,
naïve DGKζ KO CD4+ and CD8+ T cells displayed enhanced
upregulation of activation markers CD25 and CD69 and
increased proliferation compared to WT T cells. The increased
expression of activation markers was associated with enhanced
phosphorylation of ERK but normal induction of non-DAG
mediated pathways including Ca2+ flux and JNK activation.
Importantly, bypassing TCR activation with a DAG analog,
phorbol-12-myristate-13-acetate (PMA), abolished differences in
activation betweenDGKζ KO andWTT cells, suggesting that the
hyperactivation of DGKζ KO T cells was secondary to defective
regulation of DAG.
In agreement with enhanced TCR signaling, DGKζ KO
T cells also display improved anti-viral responses (Zhong
et al., 2003). DGKζ KO mice infected with LCMV Armstrong
showed enhanced viral-specific T cell responses as evidenced by
decreased viral titers at day 7 following infection. This effect
correlated with an increased number of total and CD44hiCD62Llo
effector CD8+ T cells in the spleen. Furthermore, LCMV-infected
DGKζ KO mice exhibited increased number of IFNγ-producing
CD8+ and CD4+ T cells when restimulated with LCMV-specific
peptides, suggesting that DGKζ KO T cells displayed enhanced
effector function following LCMV infection.
Similarly, DGKζ -deficient mice also exhibit enhanced anti-
tumor responses. DGKζ KO mice subcutaneously injected with
OVA-expressing EL4 T cell lymphoma, had significantly reduced
tumor mass compared to their WT counterparts (Riese et al.,
2011). This effect was accompanied by an increased number
of total and antigen-specific tumor-infiltrating CD44hiCD8+ T
cells. To show that T cells were responsible for the enhanced
anti-tumor effect by DGKζ deficiency, DGKζ KO and WT
OVA-specific OT-I T cells were adoptively transferred into naïve
recipient WT mice. Mice receiving DGKζ KO compared to
WT OVA-specific OT-I T cells also exhibited lower tumor mass
upon challenge with OVA-expressing EL4 cells. Isolation of
tumor-infiltrating OT-I cells revealed that the loss of DGKζ
increased the frequency of CD44hi and IL-2-producing OT-I
cells in a cell-intrinsic manner. In addition to preventing tumor
engraftment, DGKζ deficiency also improves tumor rejection
of established tumors, as the adoptive transfer of DGKζ KO
but not WT OT-I effector T cells into tumor-bearing mice
significantly reduced tumor burden (Riese et al., 2013). Thus,
DGKζ could represent a novel target for enhancing anti-tumor
responses in adoptive immunotherapy. This could also be applied
to engineered T cells that express chimeric antigen receptors
(CAR) directed against the tumor, as DGKζ deficiency was also
shown to promote CAR T cell-mediated anti-tumor responses
(Riese et al., 2013). How DGKζ deficiency augments anti-tumor
responses is unclear. Although DGKζ KO CD8+ T cells display
increased cytokine production and increased proliferation, their
cytotoxic function is comparable to WT CD8+ T cells (Riese
et al., 2011). Nevertheless, these studies demonstrate that DGKζ
serves to constrain T cell activation and anti-viral and anti-tumor
T cell responses. Thus, inhibition of DGKζ might provide a
therapeutic opportunity to enhance immune-mediated viral and
tumor clearance.
It is possible that DGKζ is physiologically important for
limiting over-activation and inducing anergy in inappropriately
activated T cells. The expression level of DGKζ can be
controlled depending on the type of stimulation the T cell
receives. T cells that are stimulated through their TCR and
co-stimulatory molecules downregulate DGKζ transcript levels,
thereby allowing appropriately activated T cells to become fully
activated (Macian et al., 2002; Olenchock et al., 2006a; Zha et al.,
2006). In contrast, T cells that receive TCR stimulation alone in
the absence of co-stimulation do not downregulate DGKζ levels,
potentially leading to attenuated DAG-mediated signaling and
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decreased activation. Consistent with this notion, DGKζ KO T
cells resist anergy induction when activated by TCR alone in
the absence of co-stimulatory signals (Olenchock et al., 2006a).
In addition to TCR-mediated regulation, DGKζ might also be
regulated by environmental cytokines. In particular, IL-33 has
been shown to up-regulate DGKζ in cardiomyocytes following
stimulation (Rui et al., 2012). Although it is unknown if IL-33 can
upregulate DGKζ in immune cells, it is tantalizing to speculate
that cytokine signaling can affect the TCR responsiveness of T
cells by regulating DGKζ levels.
NK Cells
NK cells are cytotoxic members of the innate lymphoid cell (ILC)
family and play an important role in protection against viral
infection and clearance of tumors (Artis and Spits, 2015). Unlike
their adaptive counterparts (CD8+ T cells), they do not possess
a somatically-rearranged antigen receptor but rather express a
variety of activating receptors specific for ligands displayed on
virally-infected, stressed, or transformed cells (Lanier, 2008).
NK cell activating receptors can be categorized into three
main families based on the signaling adaptors used to relay
downstream activation signals. These families include SAP-
dependent (e.g., 2B4), ITAM-dependent (e.g., CD16), or DAP10-
dependent (e.g., NKG2D) receptors (McVicar et al., 1998; Wu
et al., 1999; Chen et al., 2006; Lanier, 2008). The activation
of any of these three families of receptors relies on proximal
signaling complexes involving SLP-76, which subsequently leads
to the activation of PLCγ and the production of DAG (Wu and
Koretzky, 2004; Tassi et al., 2005; May et al., 2013). In addition
to these activating receptors, NK cells express an assortment
of inhibitory receptors, many of which bind to MHC class I
alleles and negatively regulate activating receptor signaling by the
recruitment of phosphatases such as SHP-1 and SHIP (Binstadt
et al., 1996; Lanier, 2008).
NK cell activation is determined by the net balance of the
activating and inhibitory inputs that the NK cell receives through
its receptors. For example, NK cells are activated when neoplastic
cells upregulate ligands such as RAE-1 or MICA, which are
recognized by the activating receptor NKG2D (Jung et al., 2012).
Likewise, NK cells are activated through disinhibition when
tumor cells lose MHC class I, a process known as missing self
recognition (Kärre et al., 1986). Since SHP-1 and SHIP negatively
regulate activating receptor signaling, one might predict that the
loss of these molecules would boost the effector function of NK
cells. Surprisingly, however, SHP-1 and SHIP deficiency in NK
cells renders them less functional than their WT counterparts
(Lowin-Kropf et al., 2000; Viant et al., 2014; Gumbleton et al.,
2015). One explanation of this seemingly paradoxical finding
is that NK cells continuously adjust their responsiveness to
activating stimuli in their local environment, a phenomenon
known as tuning (Höglund and Brodin, 2010). Thus, NK cells
that chronically lack inhibitory signals, such as in SHP-1 or SHIP
deficiency, require more stimulation to achieve their threshold
of activation (Lowin-Kropf et al., 2000; Viant et al., 2014;
Gumbleton et al., 2015). While NK cell tuning may protect
the host from NK cell-mediated immunopathology, this process
can hamper important effector responses against chronic viral
infections or tumors.
Although the molecular mechanism of NK cell tuning is
unknown, stimulation of NK cells with PMA and a calcium
ionophore, ionomycin, can bypass the hyporesponsiveness of
SHP-1 and SHIP KO NK cells (Viant et al., 2014; Gumbleton
et al., 2015). These data suggest that the tuning process is
proximal to PLCγ-mediated production of DAG. Thus, we
speculated that NK cells may not be able to tune their
responsiveness in response to enhanced DAG-mediated signaling
by DGKζ deficiency. Indeed, we recently demonstrated that
DGKζ KO NK cells are hyperfunctional compared to WT NK
cells (Yang et al., 2016). DGKζ KO NK cells displayed increased
cytokine production and cytotoxicity following stimulation
through ITAM, SAP, and DAP10-dependent activating receptors.
In contrast, IFNγ production by DGKζ KO and WT NK cells
was similar following stimulation with IL-12 and IL-18, which
utilize a DAG-independent signaling pathway, suggesting that
the loss of DGKζ selectively augmented NK cell responsiveness
to DAG-dependent stimuli. Like T cells, the hyperfunctionality
of DGKζ KO NK cells was dependent on enhanced ERK
signaling. Importantly, DGKζ KO mice cleared the NK cell-
sensitive RMA-S tumor more efficiently than WT mice. Thus,
the inactivation of negative regulators distal to PLCγ such as
DGKζ might prove therapeutically useful in enhancing NK cell
function.
B Cells
B cells comprise the second arm of the adaptive immune
system and are critical for the generation of protective
antibody responses during infection. The induction of antibody
production results from the stimulation of the somatically
rearranged B cell receptor (BCR) by cognate antigen (McHeyzer-
Williams and McHeyzer-Williams, 2005; Kurosaki et al., 2010).
Similar to the TCR, activation of the BCR leads to downstream
biochemical cascades that ultimately result in the generation
of DAG through PLCγ and, subsequently, the activation of
ERK (Hashimoto et al., 2000; Saijo et al., 2003). ERK has
been shown to play multiple roles during B cell responses,
including the promotion of B cell survival, proliferation, and
differentiation into antibody-secreting plasma cells (Richards
et al., 2001; Coughlin et al., 2005; Yasuda et al., 2011).
Furthermore, attenuation of ERK activation has been shown to
important during B cell development, since ERK signals decrease
as B cells progress from the immature transitional stage tomature
follicular B cells (Yasuda et al., 2008; Gross et al., 2009; Rowland
et al., 2010).
Given the role of ERK in these B cell processes, controlling the
levels of BCR-induced DAG through DGKζ might be important
in regulating B cell development, activation, and antibody
secretion capabilities. For example, mRNA transcripts of DGKζ
are upregulated as B cells progress from early transitional to
the mature follicular stage, which is associated with decreased
ERK activation (Wheeler et al., 2013). Accordingly, the loss of
DGKζ only affected ERK activation and IκBα degradation in
the follicular but not early immature transitional B cell pool in
response to BCR stimulation. Importantly, the augmentation of
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BCR-induced activation in DGKζ KO follicular B cells was seen
even under less optimal BCR activation conditions, suggesting
that DGKζ might control the BCR activation threshold in these
cells.
The effects of DGKζ on B cell signaling threshold translate
to functional consequences on B cell effector responses. BCR
stimulation of purified DGKζ KO splenic B cells in vitro led
to increased expression of CD69 and enhanced proliferation
compared to WT B cells. DGKζ KO mice displayed enhanced
antibody responses to T-independent and T-dependent antigens
(Wheeler et al., 2013). The heightened antibody response
by DGKζ -deficiency was accompanied by increased antigen-
specific expansion of both germinal center (GC) B cells and
plasma cells. These results demonstrate that regulation of DAG-
dependent ERK activation by DGKζ is critical for selectively
controlling the activation threshold ofmature B cells to limit their
activation.
THE IMMUNOMODULATORY ROLE OF
DGKζ
We have so far described how the loss or inhibition of DGKζ can
lead to increased immune responses against viruses or cancer. As
DGKζ is a negative regulator of DAG-mediated signaling, it is
conceivable that immune responses would be enhanced in the
absence of DGKζ . However, DGKζ deficiency may also lead to
dampening or regulation of immune responses. In the sections
below, we will discuss how the absence of DGKζ can direct and
indirectly suppress or modulate rather than enhance immune
responses.
Regulatory T Cells
Regulatory T cells (Tregs) are a key subset of T cells that
display suppressive function and are important for the regulation
of adaptive immune responses. Tregs are governed by the
master transcription factor, forkhead box P3 (Foxp3), and
exert their immunosuppressive function via the production of
immunoregulatory cytokines and through cell contact dependent
mechanisms (Josefowicz et al., 2012). Loss of function mutations
in the Foxp3 gene, as seen in Scurfy mice and humans
with immune dysregulation, polyendocrinopathy, and X-linked
lymphoproliferative disease (IPEX), leads to lethal systemic
autoimmunity early in life, highlighting the importance of Tregs
in inducing immunotolerance against self antigens (Chatila et al.,
2000; Bennett et al., 2001; Brunkow et al., 2001; Wildin et al.,
2001).
T cells that strongly recognize self antigens are deleted
during thymic development in a process known as negative
selection. Specifically, T cells that receive strong TCR signals in
the thymus, implying overt self reactivity, undergo apoptosis.
As an alternative fate, strong TCR stimulation in developing
thymocytes can also lead to Treg differentiation (Josefowicz
et al., 2012). Thus, we hypothesized that enhancement of TCR-
mediated DAG signaling by DGKζ deficiency in developing
thymocytes may increase Treg generation. Indeed, the loss of
DGKζ resulted in a significant increase in Treg development
in the thymus in a cell-intrinsic manner (Schmidt et al., 2013).
DAG-mediated signaling leads to the activation of the NF-κB
(through activation of PKC) and ERK pathways. One NF-κB
family member, c-Rel, was previously shown to be important for
inducing Foxp3 expression in thymocytes (Long et al., 2009; Ruan
et al., 2009). Although Treg generation in DGKζ KO mice was
reduced in the absence of c-Rel, there was still residual Tregs in
the thymus, suggesting that c-Rel was only partially responsible
for the increased generation of Tregs in DGKζ KOmice (Schmidt
et al., 2013). In fact, ERK activation appeared to be more
important in the enhancement of Treg generation in DGKζ KO
mice. Using an in vitro Treg development assay, we found that
the inhibition of ERK phosphorylation by a MEK inhibitor led to
decreased Treg generation in a dose-dependent manner, whereby
the level of phosphorylated ERK (pERK) directly correlated to
the magnitude of Treg generation. Importantly, Treg generation
was also increased in sevenmaker mice (Sharp et al., 1997), which
express a gain of function ERK mutation that leads to increased
resistance to dephosphorylation of active pERK, suggesting that
the selective enhancement of the ERK pathway alone is sufficient
to increase Treg generation.
In addition to Treg generation in the thymus, TCR signaling
plays an important role in the function of Tregs. Although some
Treg function may be preserved in the absence of TCR signaling,
we demonstrated that Tregs lacking SLP-76 cannot suppress
TCR-driven proliferation of conventional T cells (Schmidt et al.,
2015). Furthermore, Tregs with a Y→F mutation at tyrosine 145
(Y145F) of SLP-76, which leads to defective PLCγ activation, also
display attenuated suppressive function, suggesting that PLCγ
is important for Treg function. Consistent with this notion,
Tregs lacking DGKζ display significantly increased suppression
of TCR-driven conventional T cell proliferation compared to
WT Tregs. Together, these data demonstrate that DGKζ limit
Treg generation and function. Thus, DGKζ deficiency may
indirectly lead to the suppression of immune responses through
Tregs.
Mast Cells
Mast cells are critical mediators in type 2 immune responses
involved in protection against helminthes and in pathologic
responses in asthma and allergy (Locksley, 2010; Voehringer,
2013). A key feature of mast cell function is the immediate
release of pre-formed inflammatory mediators such as histamine,
cytokines, and proteases in a process called degranulation. In
addition, mast cells produce arachidonic acid metabolites and
cytokines in a protracted manner (Voehringer, 2013). One major
stimulus for the release of these inflammatory mediators is
crosslinking of FcεRI, the high affinity receptor for the Fc region
of immunoglobulin E (Kinet, 1999).
The interaction of allergens with IgE-FcεRI complexes results
in formation of signaling complexes that converge on the
activation of PLCγ (Atkinson et al., 1992; Schneider et al., 1992).
PLCγ and subsequent PKC activation have been shown to be
critical in controlling mast cell degranulation, suggesting that
controlling the levels of DAG might be important for regulating
this process (Nechushtan et al., 2000; Wang et al., 2000; Leitges
Frontiers in Cell and Developmental Biology | www.frontiersin.org 4 September 2016 | Volume 4 | Article 96
Singh and Kambayashi Immunomodulation by DGKζ Inhibition
et al., 2002; Wen et al., 2002). Indeed, the loss of DGKζ in FcεRI-
stimulated mast cells leads to increased DAG levels, along with
enhancement of downstream DAG-dependent signals, including
RasGTP and ERK (Olenchock et al., 2006b). Accordingly, DGKζ
deficiency leads to enhanced mast cell production of IL-6
following FcεRI stimulation.
Intriguingly, however, FcεRI-stimulated DGKζ KOmast cells
display impaired degranulation and are resistant to local skin
anaphylaxis (Olenchock et al., 2006b). The differential effect of
DGKζ deficiency on mast function (the hypersecretion of IL-6
vs. decreased degranulation) may be explained by the negative
feedback of DAG on PLCγ activation in mast cells. The elevation
of DAG by DGKζ deficiency appears to negatively regulate
the phosphorylation and subsequent activity of PLCγ. Thus,
although DAG accumulates, the production of IP3, and hence
Ca2+ flux is attenuated in DGKζ KOmast cells. As degranulation
responses are highly dependent on elevation of intracellular
Ca2+ levels, this may cause a differential effect on degranulation
and cytokine production by mast cells (Ozawa et al., 1993;
Olenchock et al., 2006b). Thus, as opposed to T cells andNK cells,
DGKζ exerts both activating and inhibitory effects on mast cell
functional responses.
Macrophages and Dendritic Cells
Macrophages and dendritic cells (DC) play a key role in bridging
the adaptive and innate immune responses (Medzhitov, 2001;
Janeway andMedzhitov, 2002; Akira and Takeda, 2004). Toll-like
receptors (TLR) serve as an important mechanism for equipping
macrophages and DCs with the ability to recognize the presence
of pathogenic infection and, subsequently, instruct adaptive
immune cells on the type of response needed to effectively clear
the infection. TLRs can signal through either MyD88 and/or
TRIF to induce activation of the NF-κB and ERK pathways (Akira
and Takeda, 2004). While TLR activation does not generally
lead to PLCγ activation, DAG has been shown to be induced
in macrophages following stimulation with LPS (TLR4 agonist)
and lipopeptide (TLR2 agonist) (Monick et al., 1999; Zhang
et al., 2001a,b). Furthermore, inhibition of PLC or PLD reduced
cytokine production and nitric oxide formation by macrophages
following TLR stimulation, suggesting that control of DAG levels
through DGK might be important in regulating TLR-mediated
responses.
Interestingly, modulation of DAG levels by the loss of
DGKζ resulted in impairment rather than enhancement of
cytokine production by macrophages and DCs in response to
TLR stimulation. Specifically, in a developmentally independent
manner, bone marrow derived macrophages (BMM8) and
splenic DCs produced substantially less IL-12p40 and TNFα
following in vitro stimulation through a variety of TLR agonists
(Liu et al., 2007). This paradoxical finding may be explained by
the role of DGK in converting DAG into PA. Biochemical analysis
revealed that the loss of DGKζ resulted in selective elevation
of the PI3K-Akt pathway but no difference in activation of the
ERK or NK-κB pathways following TLR stimulation. Activation
of the PI3K pathway has been shown to negatively regulate
TLR stimulation (Fukao et al., 2002; Guha and Mackman,
2002; Martin et al., 2005) and chemical inhibition of the
PI3K restored LPS-induced IL-12p40 production from DGKζ
KO BMM8s (Liu et al., 2007). Intriguingly, the addition of
PA also restored LPS-induced IL-12p40 production, suggesting
that the cytokine production defect in DGKζ KO DCs
and macrophages may be due to reduced PA rather than
elevated DAG levels. Exactly how PA rescues TLR-induced
cytokine production is unknown, but one possible mechanism
is through the recruitment of SHP-1 to negatively regulate PI3K
activation (Cuevas et al., 1999; Frank et al., 1999; Zhang et al.,
2003).
Defective cytokine production was also observed in vivo
following intraperitoneal injection of TLR agonists, which
correlated with enhanced survival of DGKζ KO mice after LPS-
induced septic shock (Liu et al., 2007). However, while DGKζ
KO mice were protected from TLR-mediated pathology, the loss
of DGKζ conferred susceptibility to Toxoplasma gondii. DGKζ
KO mice infected with T. gondii displayed decreased serum IL-
12p40 and IFNγ levels compared to WT mice. Furthermore,
IFNγ production by DGKζ KO splenocytes isolated at day
15 and 30 post-infection was significantly attenuated following
restimulation with T. gondii antigen STAg. Intriguingly, total
CD4+ and CD8+ T cell numbers were similar between WT
and DGKζ KO mice following infection with the frequency of
CD44+CD62lo effector T cells higher in infected DGKζ KO
mice. As TLR-induced IL-12p40 production and the subsequent
induction of a Th1 response are critical for protection against
T. gondii infection, the impairment of immune responses
against T. gondii by DGKζ KO mice could be secondary to a
defect in macrophage and DC-derived cytokines that drive Th1
responses.
THE ROLE OF OTHER DGK ISOFORMS ON
DGKζ -REGULATED IMMUNE FUNCTION
So far, we have discussed isoform-specific regulation of immune
function by DGKζ , however it is possible that the loss
of DGKζ has other functional consequences that might be
masked by redundant functions of other DGK isoforms.
Indeed, DGKα has been shown to display some redundant
function with DGKζ during conventional T and invariant NKT
cell (iNKT) development. While singly-deficient DGKα KO
and DGKζ KO mice display no gross defects in thymic T
cell development, mice deficient in both DGKα and DGKζ
(DGKαζ DKO) have significant reductions in CD4 and CD8
SP populations in the thymus due to a cell-intrinsic block in
positive selection from the DP to SP stage (Guo et al., 2008).
Interestingly, the addition of PA to fetal thymic organ cultures
could partially restore T cell maturation defect in DGKαζ
DKO thymocytes, suggesting that DGKα and DGKζ regulate
T cell development partly through redundant production
of PA.
Similarly, the development of iNKT cells is intact in mice
singly-deficient for either DGKα or DGKζ (Shen et al., 2011).
However, the loss of both DGKα and DGKζ results in a complete
impairment of iNKT cell maturation in the thymus, spleen,
and liver at both early and terminal stages in a cell-intrinsic
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manner. Selective enhancement of the ERK pathway through the
expression of a constitutively active K-ras resulted in a significant
reduction in mature iNKT cells due a block in Stage II to Stage
III maturation of iNKT precursors. Furthermore, augmented
activation of the NF-κB pathway through the expression of
a constitutively active IKKβ also resulted in an impairment
in iNKT maturation at both early and terminal stages of
development. These results suggest that DGKα and DGKζ
play redundant roles in the regulation of iNKT maturation by
controlling DAG-mediated activation of the ERK and NF-κB
pathways.
In addition to controlling innate and conventional T cell
development, DGKα has also been shown to promote T cell
anergy in conjunction with DGKζ . Overexpression of either
DGKα or DGKζ in Jurkat T cells induces an anergic-like state
that is highlighted by reduced DAG-dependent TCR signals
without the impairment of calcium flux (Olenchock et al.,
2006a). Similar to DGKζ KO T cells, T cells deficient in
DGKα resist anergy induction when activated through their
TCR in the absence of costimulation and during superantigen-
induced activation. Furthermore, pharmacological inhibition
of DGKα in DGKζ -deficient T cells can further enhance
proliferation and IL-2 production in response to anergy-inducing
conditions, suggesting that both DGKα and DGKζ contribute
to anergy induction in inappropriately activated T cells through
the synergistic regulation of TCR-induced DAG-mediated
signaling.
While DGKα and DGKζ can share similar functions, DGKα
does not simply compensate for all DGKζ -regulated functions.
For example, unlike DGKζ KO mice, DGKα-deficient mice do
not display an enhancement in Treg generation in the thymus
or hyperfunctional NK cell responses, thus emphasizing that
the regulation of these processes by DGKs is isoform-specific
and unique to DGKζ (Joshi et al., 2013; Yang et al., 2016).
The independent and redundant roles of DGKα and other DGK
isoforms on DGKζ -regulated functions in other immune cells
remain unexplored.
CONCLUDING REMARKS
As a negative regulator of DAG-mediated signaling, one might
predict that the loss of DGKζ would universally lead to immune
activation. Interestingly, however, the inhibition of DGKζ does
not only enhance but also suppresses selective immune responses
(Figure 1). Thus, although DGKζ may represent a drug target
for enhancing cytotoxic T cell responses against cancer, it may
also simultaneously serve as a target for the treatment of allergic
responses or septic shock. In addition to activation or inhibition
of immune responses, DGKζ may also play a role in modulating
the immune response. For example, it has been shown that the
differentiation of CD4+ T cells into Th1 and Th2 subsets may be
dependent on TCR signal strength, whereby strong TCR-induced
ERK signals favor Th1 over Th2 differentiation (Yamane et al.,
FIGURE 1 | Enhancement and suppression of selective immune functions through the inhibition of DGKζ . The loss of DGKζ can result in activating or
modulatory effects on the immune response that can be therapeutically beneficial for the resolution or prevention of a variety of human diseases. The inhibition of
DGKζ has positive effects on T cells, NK cells, and B cells, which could promote immunity against cancer and infections. In contrast, the inhibition of DGKζ can
suppress immune responses by augmenting Treg development, inhibiting mast cell degranulation, and attenuating macrophage/DC cytokine release. These effects
could be beneficial in treatment of autoimmunity, asthma/allergy, and septic shock.
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2005). Thus, it is possible that DGKζ controls Th1 vs. Th2 lineage
commitment by regulating DAG-mediated ERK activation in T
cells. Although the impact of DGKζ deficiency on Th2 responses
is unknown, DGKζ KO T cells display heightened Th1-driven
anti-viral and anti-tumor responses. Thus, it would be interesting
to test whether the loss of DGKζ impairs protection against Th2-
inducing helminth infections or beneficially promotes protection
against Th2-mediated diseases such as asthma. The precise
delineation of how DGKζ controls the outcome of immune
responses will yield insight into how DGKζ could be targeted for
the treatment of various immune-mediated disorders.
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